Perbedaan Estee Gold Feet Tbk. dan Champion Pacific Indonesia Tbk.: Estee Gold Feet Tbk. diperdagangkan di Rp1.760 (kapitalisasi pasar 4,23 T, volume 24 jam 139,4 rb), sedangkan Champion Pacific Indonesia Tbk. diperdagangkan di Rp414 (kapitalisasi pasar 384,1 M, volume 24 jam 16,2 rb). Perbedaan utamanya: Estee Gold Feet Tbk. jauh lebih besar — sekitar 11× kapitalisasi pasar Champion Pacific Indonesia Tbk., dan Estee Gold Feet Tbk. lebih aktif diperdagangkan (139,4 rb vs 16,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| EURO | IGAR | |
|---|---|---|
Kapitalisasi Pasar | 4,23 T | 384,1 M |
Volume | 139,4 rb | 16,2 rb |
Lot | 1,39 rb | 162 |
Perputaran | 241,4 jt | 6,65 jt |
Harga Rata-rata | 1.731,7 | 410,64 |
Nilai Transaksi | 241,4 jt | 6,65 jt |
Harga Ekuilibrium Indikatif | 1.760 | 414 |
Volume Ekuilibrium Indikatif | 55 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Selengkapnya di halaman EURO →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Selengkapnya di halaman IGAR →